Pancreatic cancer is hard to cure and even diagnosing it is challenging. Among the eagerly awaiting research topics to be presented at the American College of Gastroenterology Meeting in Honolulu, Hawaii are reports on new developments in detecting malignancies.
There are many factors that patients diagnosed with multiple sclerosis need to consider when managing their condition. While the physical symptoms can be the highest priority, quality of life is an area which is gaining greater recognition in the field.
More than three-quarters of intravenous drug users and Baby Boomers tested for hepatitis C were positive and unaware they were infected, according to results of a study published in the journal Annals of Emergency Medicine.
Just as overactive bladder issues and constipation are an issue for patients with multiple sclerosis, mirabegron is a popular medication in the general population for managing these issues. At the NYU Langone Medical Center Comprehensive Care Center patients receive treatment from a wide variety of healthcare professionals in order to get the best results possible for their condition.
Optic neuritis is linked to multiple sclerosis and a treatment to help patients with this condition continues to work its way through the research and approval process. Unlike other areas of multiple sclerosis treatment there is no singular way to measure or determine cognitive impairment in patients.
Air pollution affects liver health and can cause fibrosis, according to findings published in the Journal of Hepatology.
Although there was widespread circulation of influenza viruses that were antigenically drifted from the vaccine virus, last year's flu vaccine appears to have been effective in preventing severe illness requiring hospitalization.
In the UK's National Health Service, physicians are "bare below the elbows" meaning they wear scrubs and not white coats, dress shirts and ties. At ID Week, in an entertaining but serious debate, two infection control specialists tackled the question of whether US physicians should also go bare.
ID Week is the most relevant and important meeting for ID as a whole.
The ECTRIMS conference may be based in Europe but as the conference has grown so has its global impact on multiple sclerosis treatment. With topics ranging from newly approved therapies to those in the pipeline to those not yet ready for testing there is lots to learn in the yearly event.
Overuse of urinary catheters is a common problem in all hospitals. Intervention is possible.
For patients with multiple sclerosis (MS), disturbances in the thermoregulation can result in episodic hypothermia. It's believed that this is caused by hypothalamic lesions from the disease, however, the specifics are not fully understood. M. Toledano and colleagues from the University of Utah set out to uncover more in a poster session that will be presented at the 31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS 2015) in Barcelona, Spain.
Katarina Fink, an associate in the Department of Clinical Neuroscience at the Karolinska Institutet in Sweden, and colleagues analyzed the influence that multiple sclerosis (MS) has on a woman's fertility – an area that has remained unclear. The findings will be described in a poster session at the 31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS 2015) in Barcelona, Spain.
Cats and dogs can be vectors for an eye parasite, a multi-center team in the US Southwest reports. The parasite is called Onchocerca lupi. Six cases, believed to be the first in the US, are reported.
Patients who are morbidly obese need a revised dosing protocol when getting vancomycin.
Even when staph bacteria are not drug resistant, clinicians face prescribing drugs that could cause an adverse reaction including kidney injury. A Pittsburgh team looked at the comparative risk of nafcillin vs. oxacillin.
The European Society of Cardiology's annual conference in London highlighted some of the top work being done in the field over the past year.
PCSK9 inhibitors have been the focus of the cardiology community and with the approval of two medications in the past few months these drugs could soon make their way to a large number of patients needing help managing their cholesterol levels using more than just statins.
Congestive heart failure is a serious condition facing people around the world. Early trials of a gene therapy have showed promise to not only help these patients with the condition but also make their hearts healthier.
Just because researchers go into a study with a hypothesis they hope to prove, it does not mean the results will be what they were hoping for.
Several large groups combined data to look at results of a study on heart failure patients to see whether age and gender affected treatment options prescribed by patients.
Treating one patient for an illness can answer some questions for doctors. However, in many cases looking at the larger patient population can answer not only why the patients got sick, but what can be done to keep them healthy in the long run.
In the time since Florence Nightingale first developed the profession of nursing as it is known today a lot has changed for the men and women in the field. Even still the work they do has been a key part of the medical world as training has increased and improved as well.
The glucose-lowering medication lixisenatide was found not neither increase nor decrease cardiovascular (CV) events compared with placebo in patients afflicted with type 2 diabetes and acute coronary syndrome.
There could be a new first-line treatment for hypertension in patients needing diuretic therapy, according to research presented at the European Society of Cardiology (ESC) Congress conference in London, UK.
In heart failure patients with diabetes and/or chronic kidney disease, a new, non-steroidal mineralocorticoid receptor antagonist called finerenone was no more effective than the currently approved MRA eplerenone in reducing the heart failure biomarker N-terminal pro-B-type natriuretic peptide. But it had other benefits.
It was less than two decades ago that researchers uncovered the role of PCSK9 in a person's body. In just the past few months two new medications have been developed that could go a long way in helping win the fight against bad cholesterol.
A considerable amount of progress has been made in treating diabetes this year both for type 1 and type 2 diabetes. The approval of new medications and potential devices in the future have made for a bright outlook for patients.
Patients with C-Diff are being treated with fecal microbiota transplantation but there is still more research being done in the field to learn more about the potential benefits in the field.
Hormone therapy has proven a very effective option for many women during menopause but there has also been some evidence that it can increase the likelihood of bleeding disorders. A recent study looked at the link between the two.